The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Neha Manpuria - JPMorgan Chase & Co, Research Division - Analyst
: My first question is on the U.S. business. We have seen a fair bit of momentum in Albuterol market share over the last few quarters, I'm not even
looking at this quarter, but over the last few quarters. But our U.S. business has been sort of a range bound in the $135 million to $140 million, even
this quarter, $131 million. Is the core portfolio seeing higher-than-anticipated erosion? And when do you see the next inflection in the U.S. business
in your view?
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
PRELIMINARY
AUGUST 05, 2021 / 2:00PM, CIPL.NS - Q1 2022 Cipla Ltd Earnings Call
Question: Neha Manpuria - JPMorgan Chase & Co, Research Division - Analyst
: Okay. More in the FY '23 time thing?
Question: Neha Manpuria - JPMorgan Chase & Co, Research Division - Analyst
: Understood. And Kedar, on the operating cost, despite the second wave and lockdown, it seems like we did see some increase in operating costs
quarter-on-quarter despite the restrictions. How should we look at this cost from the current level that you reported in the first quarter? As things
have opened up completely, should we see acceleration of SG&A spend in the India business and other branded markets going ahead?
Question: Neha Manpuria - JPMorgan Chase & Co, Research Division - Analyst
: Understood. So what I'm understanding other than the fact the number that is linked to revenue, most other costs is at a normalized level in this
quarter?
Question: Neha Manpuria - JPMorgan Chase & Co, Research Division - Analyst
: Understood. And one other question, if I can squeeze in. In terms of the R&D costs, you said that the absolute number should maintain the trajectory
that we are seeing. So on an absolute basis, will the spend this year to be similar to what we've been doing in this quarter or more like FY '20, which
also included some costs from?
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
PRELIMINARY
AUGUST 05, 2021 / 2:00PM, CIPL.NS - Q1 2022 Cipla Ltd Earnings Call
|
